日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of an immunodeficiency-associated EZH2 variant

免疫缺陷相关 EZH2 变体的特征分析

de Los Santos, Francisco Perez; Beck, Lily; DeCurtis, Emily; Griffin, April M; Balas, Maggie M; Marchioni, Charlotte; Kumanovics, Attila; Taylor, Matthew R G; Jordan, Kimberly R; Kirkpatrick, Charles H; Johnson, Aaron M

Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells

对一种用于定量总T细胞相对于嵌合抗原受体阳性T细胞的多重数字PCR检测方法进行表征

Murphy, Lindsey A; Sedivy, Laura; Kohler, M Eric; Jordan, Kimberly R; Ohm, Angela; Slansky, Jill E; Yarnell, Michael; Fry, Terry J; Winters, Amanda C

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer

新型CD47阻断联合疗法治疗难治性微卫星稳定型转移性结直肠癌的II期临床试验和临床前评估

Lentz, Robert W; Lang, Julie; Pitts, Todd M; Blatchford, Patrick; Hu, Junxiao; Jordan, Kimberly R; Van Bokhoven, Adrie; Bagby, Stacey M; Dominguez, Adrian T A; Binns, Cameron A; Robinson, Hannah R; Balmaceda, Nicole; Baiyee, Emily; Leal, Alexis D; Kim, Sunnie S; Davis, S Lindsey; Lieu, Christopher H; Wadlow, Raymond C; Spencer, Kristen; Scott, Aaron J; Boland, Patrick M; Hochster, Howard S; Messersmith, Wells A

SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

SM08502 介导的 β-catenin 抑制与奥拉帕尼协同作用抑制肿瘤进展。

Corr Bradley R, Woodruff Elizabeth R, Yamamoto Tomomi M, Jordan Kimberly R, Danhorn Thomas, Bossard Carine, Nguyen Lily L, Chuong Edward B, Wick Lars, Young Alexandra, Kusumoto Shinya, Orsulic Sandra, Barroilhet Lisa, Bitler Benjamin G

Platelet-Macrophage Aggregates in Remodeled Vessels of Patients With Pulmonary Arterial Hypertension

肺动脉高压患者重塑血管中的血小板-巨噬细胞聚集体

Farrell, Christine L; Jordan, Mariah; Posey, Janelle N; Jordan, Kimberly R; Gandjeva, Aneta; Nozik, Eva S; Stenmark, Kurt R; Tuder, Rubin M; Graham, Brian B; Delaney, Cassidy A

Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinoma

清除造血干细胞来源的脂肪细胞可降低同基因小鼠高级别浆液性癌模型中的肿瘤负荷

Woodruff, Elizabeth R; Bailey, Courtney A; To, Francis; Manda, Vyshnavi; Maltzahn, Joanne K; Sullivan, Timothy M; Boorgula, Meher P; Recouvreux, Maria Sol; Vianzon, Ruby; Conrad, Bogi; Gavin, Kathleen M; Jordan, Kimberly R; Klemm, Dwight J; Orsulic, Sandra; Bitler, Benjamin G; Watson, Zachary L

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

一项评估帕博利珠单抗联合比美替尼和贝伐珠单抗增强治疗难治性微卫星稳定型结直肠癌的II期研究

Lentz, Robert W; Friedrich, Tyler J; Blatchford, Patrick J; Jordan, Kimberly R; Pitts, Todd M; Robinson, Hannah R; Davis, S Lindsey; Kim, Sunnie S; Leal, Alexis D; Lee, Mathew R; Waring, Meredith R N; Martin, Anne C; Dominguez, Adrian T A; Bagby, Stacey M; Hartman, Sarah J; Eckhardt, S Gail; Messersmith, Wells A; Lieu, Christopher H

The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma

肿瘤免疫微环境的空间结构可以解释和预测高级别浆液性癌患者的治疗反应

Van Kleunen, Lucy B; Ahmadian, Mansooreh; Post, Miriam D; Wolsky, Rebecca J; Rickert, Christian; Jordan, Kimberly R; Hu, Junxiao; Richer, Jennifer K; Brubaker, Lindsay W; Marjon, Nicole; Behbakht, Kian; Sikora, Matthew J; Bitler, Benjamin G; Clauset, Aaron

Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer

ER+/Her2-乳腺癌患者接受新辅助氟维司群联合或不联合恩扎卢胺治疗的临床和免疫反应

Elias, Anthony D; Staley, Alyse W; Fornier, Monica; Vidal, Gregory A; Alami, Vida; Sams, Sharon; Spoelstra, Nicole S; Goodspeed, Andrew; Kabos, Peter; Diamond, Jennifer R; Shagisultanova, Elena; Gallagher, Rosa I; Wulfkuhle, Julia D; Petricoin, Emanuel F; Zolman, Kathryn L; McSpadden, Tessa; Jordan, Kimberly R; Slansky, Jill E; Borges, Virginia F; Gao, Dexiang; Richer, Jennifer K

Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.

结合 EHMT 和 PARP 抑制:一种在抑制耐药性卵巢癌肿瘤生长的同时刺激免疫激活的策略

Nguyen Lily L, Watson Zachary L, Ortega Raquel, Woodruff Elizabeth R, Jordan Kimberly R, Iwanaga Ritsuko, Yamamoto Tomomi M, Bailey Courtney A, To Francis, Jeong Abigail D, Guntupalli Saketh R, Behbakht Kian, Gibaja Veronica, Arnoult Nausica, Cocozaki Alexis, Chuong Edward B, Bitler Benjamin G